Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$887,331
-$3,452,246 QoQ
Shares Held
17,933
-10.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#2,658
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Mission Creek Capital Partners, Inc. holds $22,770,041 across 9 Drug Manufacturers - General names. ABBV ranks #4 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
37,974 | $9,644,256 | |
| 2 | LLY |
ELI LILLY & Co
|
4,541 | $5,446,612 | |
| 3 | AMGN |
Amgen Inc
|
14,051 | $5,088,148 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
17,933 | $887,331 | |
| 5 | PFE |
Pfizer Inc
|
22,248 | $535,731 | |
| 6 | MRK |
Merck & Co., Inc.
|
3,080 | $395,780 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,542 | $321,156 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
4,250 | $244,885 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $887,331 | 17,933 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,339,577 | 19,953 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $6,738,627 | 29,492 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $6,884,841 | 29,735 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $5,570,084 | 30,008 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $6,380,303 | 30,452 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $5,420,560 | 30,504 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,175,873 | 16,082 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,804,523 | 16,351 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,217,613 | 12,178 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,788,508 | 11,541 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,732,524 | 11,623 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,576,206 | 11,699 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,665,097 | 10,448 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,463,216 | 9,054 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,193,932 | 8,896 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,338,618 | 8,740 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,421,218 | 8,767 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,155,368 | 8,533 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $910,530 | 8,441 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,051,607 | 9,336 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $876,798 | 8,102 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $864,271 | 8,066 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $651,231 | 7,435 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $729,379 | 7,429 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $474,892 | 6,233 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||